TCG Crossover
TCG Crossover is a healthcare investment firm dedicated to advancing disruptive medicines and supporting companies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed TCG Crossover Information
Geographic Data
Address: 228 Hamilton Avenue
City: Palo Alto
State: CA
Zip: 94301
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$824M
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
TCG X is a healthcare investment firm dedicated to advancing disruptive medicines and supporting companies that can improve the lives of patients. TCG X invests in both private and public companies led by exceptional entrepreneurs focused on developing better treatment options for patients. TCG X has investment teams in Palo Alto and New York City
Contact Phone:
+16507985495
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2021 | Magenta Therapeutics | Post-IPO Equity | 86.4M |
| 10/2022 | Immunovant | Post-IPO Equity | 75M |
| 10/2021 | ShouTi | Series B | 0 |
| 3/2021 | Aktis Oncology | Series A | 72M |
| 3/2021 | Entrada Therapeutics | Series B | 0 |
| 6/2021 | Synthekine | Series B | 0 |
| 8/2022 | Aktis Oncology | Series A | 0 |
| 6/2023 | Upstream Bio | Series B | 0 |
| 6/2021 | RayzeBio | Series C | 108M |
| 2/2023 | Abivax | Post-IPO Equity | 0 |
| 2/2022 | Plexium | Series B | 0 |
| 5/2021 | Affinia Therapeutics | Series B | 0 |
| 10/2021 | Structure Therapeutics | Series B | 0 |
| 5/2023 | Carmot Therapeutics | Series E | 0 |
| 6/2022 | Upstream Bio | Series A | 200M |
| 10/2022 | VectivBio | Post-IPO Equity | 0 |
| 11/2021 | Arbor Biotechnologies | Series B | 0 |
| 9/2022 | Abivax | Post-IPO Equity | 0 |
| 9/2022 | Allakos | Post-IPO Equity | 0 |
| 9/2021 | Alpine Immune Sciences | Private Placement | 91M |
| 7/2021 | Artios Pharma | Series C | 0 |
| 6/2022 | Upstream Bio | Series A | 0 |
| 2/2022 | Plexium | Series B | 0 |
| 11/2021 | Arbor Biotechnologies | Series B | 0 |
| 10/2021 | ShouTi | Series B | 0 |
| 9/2021 | Alpine Immune Sciences | Post-IPO Equity | 0 |
| 7/2021 | Artios Pharma | Series C | 0 |
| 6/2021 | RayzeBio | Series C | 0 |
| 6/2021 | Synthekine | Series B | 0 |
| 5/2021 | Magenta Therapeutics | Post-IPO Equity | 0 |
| 5/2021 | Affinia Therapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
